142 related articles for article (PubMed ID: 7724594)
21. Self class I molecules protect normal cells from lysis mediated by autologous natural killer cells.
Ciccone E; Pende D; Vitale M; Nanni L; Di Donato C; Bottino C; Morelli L; Viale O; Amoroso A; Moretta A
Eur J Immunol; 1994 Apr; 24(4):1003-6. PubMed ID: 8149950
[TBL] [Abstract][Full Text] [Related]
22. Evidence of a natural killer (NK) cell repertoire for (allo) antigen recognition: definition of five distinct NK-determined allospecificities in humans.
Ciccone E; Pende D; Viale O; Di Donato C; Tripodi G; Orengo AM; Guardiola J; Moretta A; Moretta L
J Exp Med; 1992 Mar; 175(3):709-18. PubMed ID: 1371301
[TBL] [Abstract][Full Text] [Related]
23. HLA-G recognition by human natural killer cells. Involvement of CD94 both as inhibitory and as activating receptor complex.
Pende D; Sivori S; Accame L; Pareti L; Falco M; Geraghty D; Le Bouteiller P; Moretta L; Moretta A
Eur J Immunol; 1997 Aug; 27(8):1875-80. PubMed ID: 9295021
[TBL] [Abstract][Full Text] [Related]
24. Interleukin-15-induced maturation of human natural killer cells from early thymic precursors: selective expression of CD94/NKG2-A as the only HLA class I-specific inhibitory receptor.
Mingari MC; Vitale C; Cantoni C; Bellomo R; Ponte M; Schiavetti F; Bertone S; Moretta A; Moretta L
Eur J Immunol; 1997 Jun; 27(6):1374-80. PubMed ID: 9209487
[TBL] [Abstract][Full Text] [Related]
25. T cell clones expressing the natural killer cell-related p58 receptor molecule display heterogeneity in phenotypic properties and p58 function.
Ferrini S; Cambiaggi A; Meazza R; Sforzini S; Marciano S; Mingari MC; Moretta L
Eur J Immunol; 1994 Oct; 24(10):2294-8. PubMed ID: 7925558
[TBL] [Abstract][Full Text] [Related]
26. The NKB1 and HP-3E4 NK cells receptors are structurally distinct glycoproteins and independently recognize polymorphic HLA-B and HLA-C molecules.
Lanier LL; Gumperz JE; Parham P; Melero I; López-Botet M; Phillips JH
J Immunol; 1995 Apr; 154(7):3320-7. PubMed ID: 7897214
[TBL] [Abstract][Full Text] [Related]
27. The repertoire of HLA-Cw-specific NK cell receptors CD158 a/b (EB6 and GL183) in individuals with different HLA phenotypes.
Frohn C; Schlenke P; Kirchner H
Immunology; 1997 Dec; 92(4):567-70. PubMed ID: 9497500
[TBL] [Abstract][Full Text] [Related]
28. CD94 functions as a natural killer cell inhibitory receptor for different HLA class I alleles: identification of the inhibitory form of CD94 by the use of novel monoclonal antibodies.
Sivori S; Vitale M; Bottino C; Marcenaro E; Sanseverino L; Parolini S; Moretta L; Moretta A
Eur J Immunol; 1996 Oct; 26(10):2487-92. PubMed ID: 8898964
[TBL] [Abstract][Full Text] [Related]
29. Cytotoxic activity of natural killer cells lacking killer-inhibitory receptors for self-HLA class I molecules against autologous hematopoietic stem cells in healthy individuals.
Grau R; Lang KS; Wernet D; Lang P; Niethammer D; Pusch CM; Handgretinger R
Exp Mol Pathol; 2004 Apr; 76(2):90-8. PubMed ID: 15010286
[TBL] [Abstract][Full Text] [Related]
30. The transmembrane sequence of human histocompatibility leukocyte antigen (HLA)-C as a determinant in inhibition of a subset of natural killer cells.
Davis DM; Mandelboim O; Luque I; Baba E; Boyson J; Strominger JL
J Exp Med; 1999 Apr; 189(8):1265-74. PubMed ID: 10209043
[TBL] [Abstract][Full Text] [Related]
31. NK cell natural cytotoxicity and IFN-gamma production are not always coordinately regulated: engagement of DX9 KIR+ NK cells by HLA-B7 variants and target cells.
Kurago ZB; Lutz CT; Smith KD; Colonna M
J Immunol; 1998 Feb; 160(4):1573-80. PubMed ID: 9469412
[TBL] [Abstract][Full Text] [Related]
32. Natural killer cells lyse autologous herpes simplex virus infected targets using cytolytic mechanisms distributed clonotypically.
Pietra G; Semino C; Cagnoni F; Boni L; Cangemi G; Frumento G; Melioli G
J Med Virol; 2000 Nov; 62(3):354-63. PubMed ID: 11055246
[TBL] [Abstract][Full Text] [Related]
33. HLA-Cw4 expression on porcine endothelial cells reduces cytotoxicity and adhesion mediated by CD158a+ human NK cells.
Forte P; Baumann BC; Schneider MK; Seebach JD
Xenotransplantation; 2009; 16(1):19-26. PubMed ID: 19243557
[TBL] [Abstract][Full Text] [Related]
34. Specific functions of human NK cells.
Ciccone E; Moretta A; Moretta L
Immunol Lett; 1992 Feb; 31(2):99-103. PubMed ID: 1740354
[TBL] [Abstract][Full Text] [Related]
35. Trophoblast cell line resistance to NK lysis mainly involves an HLA class I-independent mechanism.
Avril T; Jarousseau AC; Watier H; Boucraut J; Le Bouteiller P; Bardos P; Thibault G
J Immunol; 1999 May; 162(10):5902-9. PubMed ID: 10229826
[TBL] [Abstract][Full Text] [Related]
36. NKB1: a natural killer cell receptor involved in the recognition of polymorphic HLA-B molecules.
Litwin V; Gumperz J; Parham P; Phillips JH; Lanier LL
J Exp Med; 1994 Aug; 180(2):537-43. PubMed ID: 8046332
[TBL] [Abstract][Full Text] [Related]
37. Effect of aging on distribution and functional activity of GL183+ and EB6+ NK cells.
Mariani E; Gemma Monaco MC; Cattini L; De Zwart JF; Tripodi G; Orengo A; Facchini A
Arch Gerontol Geriatr; 1992; 15 Suppl 1():249-56. PubMed ID: 18647694
[TBL] [Abstract][Full Text] [Related]
38. Spontaneous resolution of p58/EB6 antigen restricted NK-type lymphoproliferative disease of granular lymphocytes: role of Epstein Barr virus infection.
Zambello R; Loughran TP; Trentin L; Rassu M; Facco M; Bortolin M; Nash R; Agostini C; Semenzato G
Br J Haematol; 1997 Oct; 99(1):215-21. PubMed ID: 9359527
[TBL] [Abstract][Full Text] [Related]
39. Selective inhibition of human and mouse natural killer tumor recognition using retroviral antisense in primary natural killer cells: involvement with MHC class I killer cell inhibitory receptors.
Ortaldo JR; Mason AT; Mason LH; Winkler-Pickett RT; Gosselin P; Anderson SK
J Immunol; 1997 Feb; 158(3):1262-7. PubMed ID: 9013968
[TBL] [Abstract][Full Text] [Related]
40. Protection from lysis by natural killer cells of group 1 and 2 specificity is mediated by residue 80 in human histocompatibility leukocyte antigen C alleles and also occurs with empty major histocompatibility complex molecules.
Mandelboim O; Reyburn HT; Valés-Gómez M; Pazmany L; Colonna M; Borsellino G; Strominger JL
J Exp Med; 1996 Sep; 184(3):913-22. PubMed ID: 9064351
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
